How much is ORIC Pharmaceuticals worth in 2026?

ORIC Pharmaceuticals has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has ORIC Pharmaceuticals raised?

ORIC Pharmaceuticals has raised N/A in total funding across 2 funding rounds.

ORIC Pharmaceuticals

Drug Discovery

ORIC Pharmaceuticals valuation and funding history | Last updated: May 28, 2025 | 2 funding rounds

Current Valuation

N/A

As of May 28, 2025

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$125.0M

Last Funding

May 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 28, 2025	PIPE	$125.0M	N/A	-
January 22, 2024	PIPE	$125.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

ORIC Pharmaceuticals is currently valued at N/A as of May 28, 2025.

Track ORIC Pharmaceuticals Valuation Updates

Get notified when ORIC Pharmaceuticals raises new funding or valuation changes

Explore More Data

Detailed analysis for ORIC Pharmaceuticals

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock ORIC Pharmaceuticals's valuation history, funding rounds, and growth metrics.

No credit card required

What is ORIC Pharmaceuticals Worth in 2026?

ORIC Pharmaceuticals is a leading private company in the Drug Discovery sector. Track ORIC Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How ORIC Pharmaceuticals Valuation is Determined

Private company valuations like ORIC Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.